Communication

IN THE NEWS

NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.

June 17, 2021

FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND... Read More
POTENTIAL INVOLVEMENT OF URINARY TRACT INFECTIONS IN THE DEVELOPMENT OF BLADDER CANCER

15 March 2021

Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen is proud of sharing this new publication. Background Urinary tract infections (UTIs) are... Read More
NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

3 March 2021

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset As provider of the bulk and single-cell RNA-seq libraries and sequencing, IntegraGen is proud of... Read More

NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

3 March 2021

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset... Read More
BRIEF TECHNIQUE: LOW-PASS WHOLE GENOME SEQUENCING - GETTING MORE FROM LESS

9 October 2020

LP-WGS analysis of liquid biopsies (ctDNA) for oncology applications Background Analysis of circulating tumor DNA... Read More
ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.

September 16, 2020

This press release has been prepared and issued by OncoDNA S.A. pursuant to... Read More
COMBINED GENERAL MEETING

1 September 2020

IntegraGen's Combined Ordinary and Extraordinary General Meeting will be held on September 17 at 2 pm... Read More